REQUEST A DEMO
Total
USD $0.00
Search more companies

Sinphar Pharmaceutical Co., Ltd. (杏辉药品工业股份有限公司) (Taiwan, China)

Main Activities: Chemical Manufacturing | Medicinal and Botanical Manufacturing
Full name: Sinphar Pharmaceutical Co., Ltd. Profile Updated: January 15, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Sinphar Pharmaceutical Co., Ltd. (杏辉药品工业股份有限公司) is an enterprise in Taiwan, China, with the main office in I-Lan. The enterprise currently operates in the Chemical Manufacturing sector. The enterprise was incorporated on July 02, 1977. Sinphar Pharmaceutical Co., Ltd. (杏辉药品工业股份有限公司) currently employs 941 (2023) people. The company’s latest financial report indicates a net sales revenue increase of 8.49% in Q3C2025. Its’ total assets recorded a negative growth of 2.19%. The net profit margin of Sinphar Pharmaceutical Co., Ltd. (杏辉药品工业股份有限公司) increased by 1.27% in 2025.

Headquarters
84 Chung Shan Rd.,Chung Shan Village
I-Lan;

Contact Details: Purchase the Sinphar Pharmaceutical Co., Ltd. (杏辉药品工业股份有限公司) report to view the information.

Website: http://www.sinphar.com

Basic Information
Total Employees:
Purchase the Sinphar Pharmaceutical Co., Ltd. (杏辉药品工业股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Sinphar Pharmaceutical Co., Ltd. (杏辉药品工业股份有限公司) report to view the information.
Financial Auditors:
Purchase the Sinphar Pharmaceutical Co., Ltd. (杏辉药品工业股份有限公司) report to view the information.
Incorporation Date:
July 02, 1977
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Assistant Vice President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
9.83%
Purchase this report to view the information.
6.99%
Purchase this report to view the information.
2.43%
Purchase this report to view the information.
1.88%
Purchase this report to view the information.
1.26%
Subsidiaries
Cancap Pharmaceutical Ltd.
100%
Universalnext Technologies Inc.
100%
杏力醫療器材生技股份有限公司
100%
Company Performance
Financial values in the chart are available after Sinphar Pharmaceutical Co., Ltd. (杏辉药品工业股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
8.49%
Total Operating Revenue
8.46%
Operating Profit
53.8%
EBITDA
27.6%
Net Profit/Loss for the Period
23.89%
Total Assets
-2.19%
Total Equity
2.99%
Operating Profit Margin
3.89%
Net Profit Margin
1.27%
Return on Equity (ROE)
1.21%
Debt / Equity
-5527%
Quick Ratio
-19.74%
Cash Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?